Please login to the form below

Not currently logged in
Email:
Password:

Senior appointments at Glide Pharma

New chief financial officer and director of business development

Richard BungayGlide Pharma has appointed a chief financial officer and a director of business development as it prepares to scale up its commercial efforts.

Richard Bungay joins as chief financial officer from Verona, where he had served since September last year. Prior to this he was CEO of fellow UK biotech Chroma Therapeutics having previously been the company's chief financial officer.

His other previous include director of corporate communications and strategic planning at Celltech and finance director within the respiratory and inflammation therapy area at AstraZeneca.

New director of business development Tony Mills joins Glide from Q Chip where he was chief commercial officer.

Dr Mark Carnegie-Brown, Glide's CEO, commented: “Both are seasoned industry professionals, and attracting executives of their calibre is a testament to the progress Glide has made since completing a strategic fundraising last year for the scale-up of our device and formulation capabilities.”

9th July 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics